Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes.
about
Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut MicrobiomeConcise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 DiabetesAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesISA-2011B, a Phosphatidylinositol 4-Phosphate 5-Kinase α Inhibitor, Impairs CD28-Dependent Costimulatory and Pro-inflammatory Signals in Human T Lymphocytes.Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieuGerminal centre frequency is decreased in pancreatic lymph nodes from individuals with recent-onset type 1 diabetes.Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals.Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humansThe changing landscape of type 1 diabetes: recent developments and future frontiers.Follicular helper T cell signature in type 1 diabetesPTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.Role of the gastrointestinal ecosystem in the development of type 1 diabetes.Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC TransplantationRapamycin ameliorates experimental autoimmune uveoretinitis by inhibiting Th1/Th2/Th17 cells and upregulating CD4+CD25+ Foxp3 regulatory T cells.Follicular Helper T Cells in Autoimmunity.Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus.The Role of IL-17 and Th17 Lymphocytes in Autoimmune DiseasesCan we vaccinate against Type 1 diabetes?Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissuesRegulatory properties of the intestinal microbiome effecting the development and treatment of diabetesA circulating reservoir of pathogenic-like CD4+ T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment.The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes.Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitusObstacles and opportunities for targeting the effector T cell response in type 1 diabetes.Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes.Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.Cholinergic Stimulation Prevents the Development of Autoimmune Diabetes: Evidence for the Modulation of Th17 Effector Cells via an IFNγ-Dependent Mechanism.Islet antigen-specific Th17 cells can induce TNF-α-dependent autoimmune diabetes.Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice.Interindividual variation in human T regulatory cells.TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?Autologous regulatory T cells for the treatment of type 1 diabetes.The multiple origins of Type 1 diabetes.Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.Anti-cytokine therapies in T1D: Concepts and strategies.Forkhead box P3: the peacekeeper of the immune system.Immune modulation in humans: implications for type 1 diabetes mellitus.Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review.Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction.
P2860
Q26769612-887D7A55-94DF-478F-AA4B-21BB0F8DE66AQ28071490-1D8EEFC7-1D7D-4A09-8474-81CEE430B38CQ28080791-5C019B4E-3FA3-433F-BEFE-6C0864845167Q33603302-6AA6D23E-E8A5-4C48-BB8F-2C7513A8A115Q33661671-3FC4B69E-34FC-4451-A5D4-0CDEE6F564EBQ33843700-BF4332FF-4423-4111-B48A-C2BE61FC57AFQ34586781-18AEBD8E-51E8-47D2-B2BF-78FDC43E0A94Q34756902-46F5EDFE-0E5C-4F67-9E4D-13CA07D8B1F2Q34891279-EF13BDB8-41FD-4013-BF5A-9C5A6C03398CQ35242659-3FCD91B1-D1DC-488C-B009-BFBE03DE2213Q35506437-6F252EF3-79C2-43B7-9F0E-5E28EF571DDEQ35624584-6108C810-0AB7-42B5-A4EA-EF76D358A644Q35645163-9929D1BA-E026-49C0-8C79-FB063DF8BFB0Q35964539-10A9ACAA-62AF-4E4D-B327-54C19F1E071BQ36057301-A025B3AC-CC76-4095-88D4-6A18C6F7662AQ36184263-96B9F719-D375-48DC-9636-1CF5F93FC696Q36249305-B254A09F-2329-44C9-80FB-1856FA498EA1Q36296386-E8DD5187-9034-40A4-9584-9ACE46199118Q36436829-FC84959E-101B-4ED8-AF7D-F6ED0D79B640Q36576134-7671E512-E651-41B9-80E9-B74033FA0056Q36577387-BB317F9C-DC15-4567-A9A8-5CD60C53083CQ36679011-66D76A98-FCE8-43A3-8C74-7C57094AF63CQ36762700-E1448792-3FF2-4905-9F33-F230C5CC012DQ36914125-3BAAF940-4B7C-45C8-8066-5CBAD8412BE1Q36995345-2C61C104-D667-4892-B366-3425C6623654Q37021626-36F56509-7CBB-4848-AD27-4F6D9E45F748Q37088180-6148840E-0259-4228-9AD6-2B89753EF500Q37335056-8F0B41DD-B9FA-46D0-936B-D1186246E324Q37598361-8146D20C-76F2-423F-9BD0-8AF18483DC66Q37664261-A524C76C-A0F9-4DE5-9F52-2AC09EA982C7Q37674407-167C7838-5B06-4504-A175-C1E1691823DEQ38016854-A7F670CE-6BE8-4B88-9352-1FFED1C16817Q38030480-757B7B0A-0C62-4997-8F4B-F437C5458831Q38062580-414EA304-8F7F-4B7D-A8A7-2A723B4940D1Q38071420-669F2EA2-A58C-4FB2-8F3E-292BECDEF81AQ38091182-75E80F83-D10B-4C21-AD8C-4D7990ADFC99Q38172563-3F24FE31-D41D-4ADF-BD56-0D647D358BDFQ38182297-BBD3D613-B40B-4E78-B780-0AA62BD061FCQ38236300-5669FD38-04CC-448F-9331-7DD14B9D9637Q38438986-24A57D7B-1795-4365-8790-3672896670DB
P2860
Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Expansion of Th17 cells and fu ...... patients with type 1 diabetes.
@ast
Expansion of Th17 cells and fu ...... patients with type 1 diabetes.
@en
type
label
Expansion of Th17 cells and fu ...... patients with type 1 diabetes.
@ast
Expansion of Th17 cells and fu ...... patients with type 1 diabetes.
@en
prefLabel
Expansion of Th17 cells and fu ...... patients with type 1 diabetes.
@ast
Expansion of Th17 cells and fu ...... patients with type 1 diabetes.
@en
P2093
P2860
P50
P356
P1433
P1476
Expansion of Th17 cells and fu ...... patients with type 1 diabetes.
@en
P2093
Alessandra Ferraro
Andrea Valle
Angela Stabilini
Antonio Secchi
Carlo Socci
Carlo Staudacher
Paola Maffi
P2860
P304
P356
10.2337/DB11-0090
P407
P577
2011-09-06T00:00:00Z